Moderna (MRNA) Return on Equity [ROE] (2018 - 2026)
Moderna (MRNA) reported Return on Equity [ROE] of -44.48% for Q2 2026, down 14.65 percentage points from -29.83% a year earlier and down 4.70 percentage points from the prior quarter.
Moderna (MRNA) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Moderna posted Return on Equity [ROE] of -28.87%, down 0.10 percentage points from FY2024.
- Return on Equity [ROE] has declined for four consecutive years, though with a five-year change of +11.12 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -28.77% in FY2024 (-0.18 pp), -28.59% in FY2023 (-78.86 pp), 50.27% in FY2022 (-95.81 pp) and 146.08% in FY2021 (+186.07 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q2 2024.
- Year over year, Return on Equity [ROE] has now declined in each of the last four quarters, with an average year-over-year change of +0.12 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 128.63 percentage points); the low point was Q3 2023 (a drop of 88.20 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -39.78% (Q1 2026), -31.39% (Q4 2025) and -33.27% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 4.66% |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn | -44.48% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.48% |
| Mar 31, 2026 | -39.78% |
| Dec 31, 2025 | -31.39% |
| Sep 30, 2025 | -33.27% |
| Jun 30, 2025 | -29.83% |
| Mar 31, 2025 | -32.02% |
| Dec 31, 2024 | -31.20% |
| Sep 30, 2024 | -18.82% |
| Jun 30, 2024 | -47.84% |
| Mar 31, 2024 | -44.75% |
| Dec 31, 2023 | -34.52% |
| Sep 30, 2023 | -22.80% |
| Jun 30, 2023 | 6.74% |
| Mar 31, 2023 | 25.19% |
| Dec 31, 2022 | 45.06% |
| Sep 30, 2022 | 65.40% |
| Jun 30, 2022 | 80.18% |
| Mar 31, 2022 | 93.77% |
| Dec 31, 2021 | 100.56% |
| Sep 30, 2021 | 83.92% |
Moderna Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();